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Summary: The concentrations of free fatty acids in plasma were estimated in thirty-three subjects, before and after
(24 hours and 72 hours) the Start of bromazepam oral administration in a daily dose of 6 mg (1.5 mg at 7 a.m.,
l .5 mg at 3 p.m. and 3 mg at 11 p.m.). A fourth estimation was performed 72 hours after drug discontinuation.
A control group of twelve subjects received aplacebo according to the same dosage pattern.
In comparison with the first estimation, the subsequent free fatty acid values showed a significant decrease
(p < 0.05, p < 0.05 and p < 0.001, respectively), whereas the control group showed no significant decrease
(p > 0.05).
The aim of the present article is to present the results of the three day-standard oral administration of bromazepam
on free fatty acid concentration of plasma.
All the samples, including the control group, were taken from a population free from any disease affecting adipose
tissuemetabolism.
Freie Fettsäuren, Zentralnervensystem und Bromazepam
Zusammenfassung: Bei 33 Personen wurden die freien Fettsäuren im Plasma vor und nach Beginn (24 h und 72 h)
der oralen Verabreichung von 6 mg Bromazepam pro die bestimmt. 72 Stunden nach dem Absetzen des Medika-
ments wurde die Konzentration der freien Fettsäuren erneut bestimmt. Diese Bestimmung nach demselben Schema
erfolgte auch bei einer Kontrollgrupppe von 12 Probanden, die ein Placebo erhielten.
Im Vergleich zum Resultat der ersten Bestimmung zeigen die nachfolgenden Werte eine signifikante Verminderung.
Hingegen wurde bei der Kontrollgruppe keine Abnahme festgestellt.
Zweck dieser Arbeit war die Analyse der Einwirkung von Bromazepam auf die freien Fettsäuren im Plasma nach
dreitägiger standardisierter oraler Verabreichung des Medikamentes. Die Probanden, sowohl die Patienten wie auch
die Kontrollpersonen, wiesen keine Krankheit auf, die den Stoffwechsel des Fettgewebes beeinflußt.
Introduction
The influence of the central nervous System (CNS) on
lipid metabolism and particularly, on free fatty acid
mobilization is indisputable. |ts exact mechanism, how^
ever. remains to be clarified.
The concentration of free fatty acids in plasma is gener-
ally accepted äs a sensitive measure of CNS arousal (1—6).
The purpose of the present study is to examine the
possible influence of a known CNS-acting drug, the
tranquillizer bromazepam, on the concentration of free
fatty acids in human plasma. Such an influence would
constitute indirect evidence of CNS regulation of the
mobilization of free fatty acids in man, mainly through
the hypothalamus and limbic System.
Materials and Methods
Patients
Thirty-thrce subjects, hospitalizcd for a ciinical and laboratory
investigation, were selected for the apparent absence of any
organic disease; this disease-free Status was later confirmed. To
minimisc any possible distress from the hospitalization itself, the
subjects were studied betwecn the 2nd and 3rd day after ad-
mission. All of them were in a 12-hour state of fasting during the
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four morning pcriods of observation. There was no tobacco.
coffoe or tea consumption. No subject was receiving medication,
and all subjocts were resting without excrcisc. The womcn, still in
reproiluetive agc, were studied between the lOth and 20th day of
thcir mcnstrual eycle.
The venipunctures were all purformcd by the samc physician.
\vhcn thc paticnt was still in bed, just aftcr awakening, and thc
tourniquct application did not excccd 60 scconds. Thc admin-
istered tranquillizer was thc bcnzodiazcpinc, bromazcpam
(Lcxotan® <Rochc», administcred orally.
I-our samples were takcn from cacli subject. namcly:
1. Bcforc drug administration.
U. 24 hours after thc first administration of the drug (6 mg/
24 h in doscs of 1 .5 mg at 7 a. m., 1 .5 mg at 3 p.m. and
3 mgat 11 p.m.).
111. 72 hours aftcr the first administration of thc drug, with thc
samc dosage pattcrn s above.
IV. 72 hours after drug discontinuation.
It was not possiblc to completc thc study for all subjects, becausc
somc of thcm left the hospital carlier than anticipated.
Anothcr group of subjccts (12 cascs) was uscd s a control
group. These subjects, which wcre selected under thc samc
conditions, wcrc given placebo tabicts according to thc above
dosage pattcrn.
M c t h o d
Blood was collccted into an heparinizcd syringc a t the various
time intervals stated above, cooled at 4 °C, and ccntrifuged
for 10 min at 3000 min"1 . Thc plasma was separated immcdiatcly
aftcr collcction and deep frozcn at - 20 °C for later analysis.
Plasma free fatty acids were estimatcd in duplicate by the
mcthod ofDucombe using 0.2 ml of plasma (7). For this
purposc thc rcagcnt kit No 126055 of Boehringcr Mannheim
GmbH and palmitic acid Standard were used. Thc quality of the
assay was estimatcd by mcasuring 10 rcplicatc samples of two
plasma pools (0.16 and 0.38 mmol/1). In accordance with a
previous report (8) the intraassay coefflcicnt of Variation was
lower than 5.0%. All samples of each patient wcre detcrmined
together in thc samc run immcdiately after the end of the test
period. Thc results arc givcn s thc mean of duplicate samples.
Statistical comparison between the four samples of cach subjcct
was madc by the t-pair test.
Tab. 1, Free fatty acid concentration values (μπιοΐ/ΐ plasma) of
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Comparison bet\veen values I and U (tab. l)
The free fatty acid concentrations in the first samples
(before drug administration) ranged from 125 μπιοΐ/ΐ to
815 μηιοΐ/ΐ plasma (mean value 422 ± 29.5 SEM Mmol/l),
i.e. within normal limits, except for five cases which
were a little above the upper lim it.
Values for the free fatty acid concentration of the second
samples (24 h after beginning of drug administration)
ranged from 110 μιηοΐ/ΐ to 780 μηιοΐ/ΐ plasma (mean
value 363 ± 25 SEM μπιοΐ/ΐ), i.e. within normal limits,
only one case being slightly above the upper limit.
Values for the second samples were found to be signi-
ficantly lower than those for the first samples (p < 0.05
using the t-pair statistical analysis). In 24 out of 33 cases
the values obtained were decreased from 2.9% to 58.3%
with a mean value of 23.7 ±3.4 SEM %.
In three eases a small increase was noted (mean value:
4.13 ± l .27 SEM %). In four cases an increase was noted
(mean value: 14.9 ± l .0 SEM %), whereas in two ex-
treme cases rather large increases were noted (38% and
112.7%).
Comparison between values IandIII (tab. 2)
In 29 cases out of the initial 33, where a third sample
was available (72 hours after Initiation of drug adrnini-7
stration), the free fatty acid concentrations were also
within normal limits, ranging between 98 μίηοΐ/ΐ and
808 μιποΐ/ΐ plasma (mean value: 353 ± 31 SEM μπκ>1/1).
Three cases were a little higher. In all 29 cases
the free fatty acid concentrations in· the plasma were
significantly lower (p < 0.05) in III than in I, using
the t-pair test.
In 20 cases the observed decrease ranged from 9.1% to
67.1 % (rnean vahie: 27.8 ± 2.8 SEM %), in four cases
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I ab. 2. Frcc fatty acid conccntration valucs (μπιοΐ/ΐ plasma) of
paticnts beforo ( l ) and 72 h aftcr the f rst drug administra-
tion ( I I I ) and relative changes (25 cases).
Tab. 3. Frce fatty acid conccntration values (jumol/1 plasma)
of paticnts bcforc (I) and 72 h aftcr drug disconlinuation







































































































































































































































* p < 0.001 (t-pair statistical analysis of the IV versus
the l estimation).
a small increase was observed (mean value: 7.4 ± 0.47
SEM 7t). and in five more cases a moderate increase was
observed (mean value: 18.6 ± l .15 SEM %).
Comparison between I andIV values (tab. 3)
In 25 out of 33 cases, where a fourth sample was avail-
able (72 hours after drug discontinuation), the values
obtained ranged between 115 μτηοΐ/ΐ and 786 μτηοΐ/ΐ
(mean value: 387 ± 28 SEM μτηοΐ/ΐ), that is, within
normal limits except for one which was a little above
the upper normal limit. In that group too, there was a
significant decrease (t-pair test) of the values, compared
with the first determination (p < 0.001).
The values obtained decreased in 21 cases, ranging
from 0.9% to 58.7% (mean value: 26.2 ± 3.7 SEM %);
in one case there was no difference and in three cases
the observed increase had a mean value of 7.66 ± 4.0
SEM 7f.
In 12 members of the control group (tab. 4) the free
fatty acid concentrations ranged from 201 to 472 μπιοΐ/ΐ
plasma (mean: 315 ± 26 SEM μιηοΐ/ΐ), frorn 210 to 699
μτηοΐ/ΐ (mean: 378 ± 42 SEM Mmol/l)from 268 to
635 μτηοΐ/ΐ (mean: 392 ± 37 SEM μπιοΙ/1) and from
212 to 774 μηκ>1/1 (mean: 414 ± 65 SEM μΓηοΙ/Ι) for
the I, II, III and IV measurements, respectively.
The observed changes between the I and tlie II, III and
IV measurements were revealed by the use of the t-pair
test (p > 0.05, p > 0.05, p > 0.05, respectively).
Analytically, on 9 out of the 12 members of the control
group, the free fatty acid concentrations showed a per-
centage increase between the first and the second esti-
mation ranging from 5.5% to 77.2% (mean value:
36.9 ± 9.4 SEM %) while in the remaining 3 cases
the values were decreased by 9.7% to 39.7% (mean
value: 22.4 ±8.9 SEM %).
In 9 out of the 12 cases the values between the first and
the third measurement were increased (5.8% to 91.1 %,
mean value: 44.6 ± 9.4 SEM %) and in 3 cases decreased
(4.9% to 20.4%, mean value: 13.2 ± 4.5 SEM %).
In 10 out of the 12 members in the same control group
the values obtained between the first and the fourth esti-
mation were increased (4.2% to 91.3%, mean value:
45.8 ±9.3 SEM %) and in 2 cases decreased (7.2 to
43.8%, mean vahie 25.5 ± 18.2 SEM %).
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All cases under drug adminislration were classified ac-
cording to (hc iluctuations of the values oblaincd, äs
follows:
Group A: Tliis includes 18 cases, where all the values
oblained after drug administration wcre always Iowcr
(fig. l ) lhan the firsl onc.
Group U: 7 cases wherc the observed values wcre in-
crcascd in cslimalion II and then decreascd (fig. 2).
In 5 cases llic decrease was in estimation I I I , and in
2 cases in estimation IV. In othcr words, the frec fatty
acitl values of this group-also evcntually show a
decrease.
Group C: This compriscs 6 cases where the decrease in
estimation II is followcd by an incrcase in estimation
III (fig. 3).
In 3 of them there is a decrease in eslimalion IV with
respcct l o estimation I. In 2 of them there was no IV
estimation. and in only onc case all the values rcmained
af sliglnly (5, ()%) higher levels.
Group D: This includes only l case (fig. 4) where II
and I I I wcre dccreased, followed by a slightly in-
creased(l .27")IV.
Group B: The only included case (fig. S) gave slightly
increascd values in all estimations (2.4%, 6,1 % and
1.7%, rcspectively).
Briefiy, in 18 out of 33 cases the conccntration of free
fatty acids in plasma werc dccreased in all estimations,
under dirug influencc. In 14 out of the remaining 15
cases there was a decrease in one or two estimations,
and in one case only all the values wcre a li t t lc increased
with respcct to estimation I.
In contrast, there is no statisticaJ correlation (p > 0.05)
between the obtained values in the control group, after
placebo administration (fig. 6).
Discussion
The results obtained, in all but one case, show a statistic-
ally significant decrease (p < 0.05 to p < 0.001) of the
concentrations of free fatty acids in plasma. with respect
to those before treatment.
The above-mentioned decrease in concentrations of free
fatty acids in plasma has the characteristic of being
observed after 24 h administration and persists after
the 72 hours of administration (p < 0.05) äs well äs 72
hours after bromazepam discontinuation (p < 0.001).
A lot of research work, during the last years, refers to the
CNS infiuence on the mobilization of free fatty acids
( l -5,9). The exact mechanism of such an infiuence is
still unsettled, since the clinical studies äs well äs the
experimcntal ones have lead to various hypotheses äs to
the direct or indirect infiuence of the CNS on lipid
metabolism. 11 has been shown that electrical Stimula-
tion of the hypothalamus causes a prompt elevation of
the concentration of free fatty acids in plasma (10).
Sapira et al. (11 ) found significant elevation in plasma free
fatty acids, after psychological Stimulation in volun-
teers. It is of intcrest to emphasize the gradual diminu-
tion of this reaction after the adaptation to the Stimulus
(12). Similar studies, clinical or experimentaJ, show that
any CNS Stimulation, physical (9, 10, 13) or psycho-
logical (1,4, 14), results in plasma free fatty acid eleva-
tion.
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Fig. l -6. Classification of all cases according to the fluctuations of the obtained free fatty acid concentration values.
I = Before drug administration
II =24 h aftejr first drug administration
III = 72 h after first drug administration
IV = 72 h after drug discontinuation.
On the other band, peripheral blockade of the syrnpa-
thetic "autonomic" nervous System by means of
adrenergie or ganglionic blocking agents, inhibits the
Physiologie response of increased free fatty acids after
threatening Stimuli (5, 15-18). Experimental studies
on animals pr ve the necessity of the peripheral nerve
integrity in order to maintain an equilibrium in lipid
metabolism(19).
This is probably due to the function of the autonomic
routes of the nerve. Therefore, in case of nerve section,
transmission of eiferen t autonomic impulses, chiefly
from the hypothalamus, is interrupted.
It is generally accepted that the action of the nervous
System upon free fatty acids is exerted by means of a
complicated humoral mechanism (20), This includes
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a considcrable number of hormones and peptides,
which contribute in maintaining a complex dynamic
equilibrium, by either cnhancing or inhibiting each
other in various proportions (21). The substances
known tö be active in lipid mobilization, from adipose
tissue, include adrenal steroids, glucagon, somatostatin,
endo hins and enkephalins (22) and the hypophyseal
honnones vasopressin, thyrotropin, corticotropin, pro-
lactin, somatotropin and the (3- and 7-lipotropins (20),
but the most important hormones regulating lipolysis
are the neural and circulating catecholamines. The in-
crease of catecholamines results in the elevation of the
concentration of free fatty acids in plasma. The main
pathway of catecholamine action on lipolysis is
believed to be through the activation of adenylate
cyclase, leading to an increased level of cAMP, which
leads to phosphorylation and activation of triglyceride
lipase. It seems likely that other pathway s of cate-
cholamine lipolysis, non cAMP-dependent, may also
exist but their exact action remains unclear äs yet (23).
On the other hand, it is well-known that the catechol-
amine plasma concentration is elevated during the state
of "stress" which rfcsults form the arousal of CNS (17).
Thus the concentration of free fatty acids in plasma
expresses one of the biochemical parameters of
"stress".
Many investigators (9, 24-27) have worked on the
response of free fatty acid concentrations in plasma
to the administration of tranquillizers acting on the
CNS. These studies were either performed on ex-
perimental animals or the tranquillizer was admin-
istered after induced hyperlipidaemia (26) or experi-
mental neural Stimulation. In these studies the esti-
mation of free fatty acids was performed only after
a single dose of the drug under investigation. Thus a
comparison of our results with those concerning other
benzodiazepines is not possible, because in the present
study the administration of the tranquillizer is con-
stant and of a long duration, imitating the usual clinical
administration. This kind of administration plus the
pharmacokinetic properties of bromazepam (half-life .
time 21—24 h, regulär elimination due to the absence
of other active metabolites) (28) limits the role of inter-
individual variations of plasma bromazepam concentra-
tions. In addition, the timing of estimations of free
fatty acid concentration in plasma, äs already described,
examines both the cumulative phase and the steady
state of bromazepam plasma concentration. Througji-
out this "steady state" phase intrasubject fluctuations
were limited to a large extent.
The presence of active bromazepäm plasma concentra-
tions during the drug administfation was judged by the
clinical appearance of the patients i.e. theif behavioural
arousal level. They were slightly somfiolent, whereas
before the first dose they were normally wake. Finally
the opinion that benzodiazepmes exert a direct action
on the releasing rate of free fatty acids fröm adipose
tissue is excluded by the results of in vitro studies (9).
We consider that OUT findings are more relevant to the
true action of the drug, because the significänt decrease
of free fatty acids was observed in individüals under
normal conditions, without a previous deviation of
their neural or metabolic functions. Furthermore, con-
tinuous drug administration represents a more constant
action on the concentration of free fatty acids in plasma
and is closer to the routine practice, where the tranquill-
izer is not administered in a single dose. In conclusion.
our findings constitüte one more indication that CNS
Inhibition causes a decisive control over lipid mobiliza-
tion, reducing the concentration of free fatty acids in
plasma.
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